Detalhe da pesquisa
1.
Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.).
J Med Primatol
; 50(1): 36-45, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219623
2.
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.
Emerg Infect Dis
; 25(8): 1511-1521, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31298654
3.
Standardization, validation, and comparative evaluation of a faster and high-performance test for quantification of yellow fever neutralizing antibodies.
J Immunol Methods
; 522: 113568, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748728
4.
3ß-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp/ABCB1 activity or expression.
Invest New Drugs
; 30(1): 105-13, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20814731
5.
Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies.
Biologicals
; 40(6): 399-404, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23034357
6.
Effects of 3ß-acethyl tormentic acid (3ATA) on ABCC proteins activity.
Int J Mol Sci
; 13(6): 6757-6771, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22837662
7.
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.
Front Immunol
; 10: 2192, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31616412
8.
Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.
Am J Trop Med Hyg
; 98(2): 420-431, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29231157
9.
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.
PLoS Negl Trop Dis
; 12(6): e0006462, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29879134
10.
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults.
Rev Inst Med Trop Sao Paulo
; 59: e2, 2017 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28380113
11.
Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies.
J Immunol Methods
; 448: 9-20, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28514646
12.
CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients.
PLoS Negl Trop Dis
; 10(12): e0005219, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27941965
13.
CD4/CD8 Ratio Predicts Yellow Fever Vaccine-Induced Antibody Titers in Virologically Suppressed HIV-Infected Patients.
J Acquir Immune Defic Syndr
; 71(2): 189-95, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26361176
14.
Booster dose after 10 years is recommended following 17DD-YF primary vaccination.
Hum Vaccin Immunother
; 12(2): 491-502, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26360663
15.
16.
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination
Artigo
em Inglês
| ARCA | ID: arc-27025
17.
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
Rev. Inst. Med. Trop. Säo Paulo
; 59: e2, 2017. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-842764
18.
Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever.
Arthritis Rheumatol
; 67(2): 582-3, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25418753
19.
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil
Artigo
em Inglês
| ARCA | ID: arc-39802
20.